首页 正文

Effectiveness and Controversy of Convalescent Plasma Therapy for Coronavirus Disease 2019 Patients

{{output}}
Since the coronavirus disease 2019 (COVID-19) began to spread, it remains pandemic worldwide. The European Medicines Agency's human medicines committee and Food and Drug Administration have only granted a conditional marketing authorization for remdesivir to t... ...